The capacity of endothelin-l to induce severe reductions in cerebral blood flow and ischaemic neuronal damage was assessed in anaesthetised rats. Endothelin-I (25 ",, 1 of 10-7 _10-4 M) was applied to the adventitial surface of an exposed middle cerebral artery and striatal blood flow assessed by the hydrogen clearance tech nique. Endothelin-l induced severe dose-dependent re ductions in cerebral blood flow (e.g., minimum CBF at 10-5 M of 9 ± 11 ml 100 g-I min -I compared to 104 ± 22 ml 100 g -I min -I with vehicle, p < 0.05), which per-Abbreviations used: FAM, formaldehyde:glacial acetic acid:absolute methanol; MeA, middle cerebral artery.
Arterial spasm associated with subarachnoid haemorrhage is of enormous clinical importance. For many years, scientists have endeavoured to dis cover the identity of the substance responsible for or capable of inducing cerebral arterial spasm, and more than a dozen substances in circulating blood have been implicated (Allen et al., 1974; White et aI., 1975; Wilkins, 1987) . However, since vasoac tive effects were found to be short lived and did not lead to the persistent narrowing of cerebral vessels observed after subarachnoid haemorrhage, none has maintained a sustained interest (Findlay et aI., 199 1) .
Endothelin-l was recognised as a potent cerebro vascular vasoconstrictor in the seminal paper by Yanagisawa et ai. (1988) reporting the chemistry, gene sequence, and pharmacology of this 21 amino acid peptide. Subsequently, two additional homol ogous genes that predict similar vasoconstrictor peptides, endothelin-2 and endothelin-3, have been described (Inoue et al., 1989) . Within the CNS, en dothelin-l is known to be synthesised and stored within the endothelium of cerebral vessels (Y oshi moto et aI., 1990) , and both endothelin-l and -3 have been identified in neurones (Giaid et aI., 1989; Lee et aI., 1990) and glia (MacCumber et aI., 1990; Ehrenreich et aI., 1991) . Binding sites for the endo thelins are also present on CNS neurones (Daven port and Morton, 199 1), glia (Ehrenreich et aI., 1991) , and cerebrovascular smooth muscle (Hoyer et aI., 1989) . Data from in vitro, in situ, and in vivo studies have established endothelin-l as a potent vasoconstrictor of cerebral vessels, capable of sig nificantly reducing cerebral blood flow (Asano et al., 1989; Robinson et aI., 1990; Macrae et al., 1991) .
The aim of the present study was twofold. First, the potency and duration of the effects of endothe lin on the cerebral vasculature were investigated in vivo by monitoring striatal CBF changes following application of peptide onto the adventitia of the middle cerebral artery (MCA) and, second, endo thelin was used as a tool to produce severe, sus tained, but ultimately reversible MCA occlusion to provide an animal model that combines a primary focal cerebral ischaemia with a secondary phase of reperfusion.
MATERIALS AND METHODS
All investigations were performed on male Sprague Dawley rats (350-450 g, Harlan Olac Ltd., Bicester, U.K.). Anaesthesia was induced and subsequently main tained with halothane (5%, then 0.5-1%) in nitrous ox ide:oxygen (70:30). A tracheal cannula was surgically im planted and intermittent positive pressure ventilation commenced. One femoral artery was cannulated for con tinuous blood pressure monitoring and for regular sam pling of arterial blood for gas tension and pH measure ment. Animals were maintained normotensive (MABP > 80 mm Hg), normocapnic (34 < Pac02 < 42 mm Hg), adequately oxygenated (Pa02 > 100 mm Hg), and normo thermic throughout the experiments.
The left MCA was exposed using a modification of the method described by Tamura et al. (1981a) . Briefly, through a 2 cm skin incision, the temporalis muscle was incised and stripped subperiosteally from the lateral and ventral aspects of the temporal bone to enter the in fratemporal fossa. The muscle strip was extended to ex pose the medial wall of the infratemporal fossa from the foramen opticum rostrally to the foramen ovale caudally. A small subtemporal craniectomy was made, centred 3 mm rostral to the foramen ovale, and the dura opened by a cruciate incision using a 25-gauge needle. The arachnoid was perforated six to eight times alongside the MCA to improve peptide access. A short vinyl cannula (OD of 0.61 mm x 5 cm) was inserted into the cavity with the tip adjacent to the exposed MCA, sutured to the surrounding muscle, and the wound closed. This procedure prevented subsequent drying or temperature changes to the exposed brain tissue during the experiment and allowed direct ap plication of peptide to the exposed artery. Data are pre sented in relation to the concentration of peptide applied to the MCA via the cannula [porcine endothelin-l (Penn insula, St. Helens, U.K.), 10-7 _10-4 M in 25 ILl of sterile saline]. This represents application of minute amounts of the peptide (e.g., 2.5 nmol for 10-4 M).
Hydrogen clearance measurement of striatal blood flow
Following MCA exposure and cannula placement, an imals were positioned in a stereotaxic frame and hydro gen clearance electrodes implanted bilaterally in the ven trolateral striatum. Hydrogen electrodes were made from 5 cm lengths of Teflon-covered platinum wire (0.005 in. in diameter with 0.00) in. Teflon coating-Clark Electro medical, Reading, England) with a 1 mm tip of exposed platinum and 2-3 mm exposed at the distal end for con nection to the recording circuit.
The incisor bar on the sterotaxic frame was positioned -3.3 mm below the interaural line and the following ste-rotaxic coordinates used: RC on bregman, 3 mm lateral to the midline, and 7 mm below the dura. Following elec trode placement, burr holes were sealed with cyanoacry late glue and fixed in place with dental cement. The elec trodes were connected to a reference circuit providing a fixed polarising voltage of -0.7 V and the animal allowed to stabilise for 30 min. Hydrogen (400 cc/min) with oxy gen (500 cc/min) and halothane (1%) was delivered to the animal via a second respiratory pump. Both pumps were connected to the tracheal line via a three-way tap to allow rapid switching of gas mixtures and ventilation adjusted until blood gases were equilibrated between the two sys tems. A hydrogen saturation period of 10 min was fol lowed by 10 min for clearance. The CBF was calculated using the initial slope index method. Data were collected over a 20-s period, 60 s after the hydrogen gas mixture had been switched off. The data were fitted to an exper imental curve and the flow calculated from the slope (Young, 1980) . The first minute of the clearance curve was discarded to avoid artifacts due to recirculating arte rial H2• At least four control values for the striatal CBF were recorded at the start of each experiment and the animal saturated with hydrogen for 10 min pre and post application of endothelin when the first flow measure ment in the presence of the peptide was made. Subse quently, flow measurements were made every 20 min for 4 h. An electrolytic lesion was made by passing current through the electrodes at the end of the experiment for subsequent histological verification of electrode place ment.
Volumetric assessment of ischaemic brain damage
In a second series of experiments, endothelin-l was applied to the exposed MCA of anaesthetised rats, ani mals were kept normothermic, and blood gases main tained within the normal range for 4 h. Rats were then perfusion fixed for neuropathological analysis with 40% formaldehyde, glacial acetic acid, and absolute methanol (FAM; 1:1:8, v/v/v). Briefly, the animals were deeply anaesthetised with 2% halothane and placed in a supine position so that the thorax could be opened through a midline incision. A catheter was inserted into the left ven tricle, the right atrium was incised, and heparinized saline was infused at a pressure equal to the MABP of the ani mal until the perfusate from the right atrium was blood less. The saline was followed by -200 ml of FAM. The animals were decapitated immediately after perfusion fix ation, and the head was stored in the fixative for at least 24 h. The brain was then removed. After detaching the hindbrain, the forebrain was cut into four equally spaced coronal blocks that were processed, embedded in paraffin wax, and sectioned at multiple levels (about 100 sections per brain). The sections, stained with hematoxylin--eosin or with a combination of cresyl violet and Luxol fast blue, were examined by light microscopy by one of us (D.I.G.) without knowledge of the experimental protocol.
Areas of early cerebral infarction (Brierly and Graham, 1987) were delineated at eight preselected coronal levels from anterior 10.5 mm to anterior 1.0 mm (Osborne et al., 1987) . The areas of brain damage were drawn on scale diagrams (x4 actual size) of forebrain based on the atlas of Konig and Klippel (1963) and measured on an image analyser (Quantimet 720, Cambridge Instruments, Cam bridge, U.K.). These areas were then integrated, with the known distance between each coronal level, to determine the total volume of ischaemic tissue in each specimen.
Statistical analysis
All data presented in text, figures, and tables are ex pressed as mean values ± SD.
Statistical comparisons for CBF and neuropathological data were made using analysis of variance and Student's unpaired t test with a Bonferroni correction for multiple comparisons.
Power analysis was used to predict the group size re quired to detect a 50% change in infarct volume in the endothelin model and (from previously published data) in the .permanent MCA occlusion model under the same conditions. Group size was calculated for a power of 80% and with a significance level of 5% using standard devia tion values for each model and the standard equation for power analysis.
RESULTS

Physiological variables
In both blood flow and neuropathology studies, blood gases, pH, and body temperature were within the normal range (Table 1 ) and were not influenced by endothelin application to the MCA. In general, endothelin did not affect the mean arterial pressure (MAP) although a small transient drop in pressure «15 mm Hg within the first 5 min) was observed in some animals with the higher concentrations of en dothelin.
Alterations in striatal CBF after endothelin applications
Endothelin-l (25 fll of 10 -7 _10 -4 M) applied to the left MeA induced an initial rapid and statisti cally significant reduction in cerebral blood flow proceeded by a slow but progressive return of flow in the ipsilateral striatum (Fig. 1) . The initial oli gaemia was dose related with the nadir between 10-20 min after endothelin ( Fig. 2A ) and ranged from a 70% reduction in flow at the lowest dose to a 96% reduction in flow at the highest dose. Endothelin-l had an extremely prolonged duration of action with Tlh (time taken for flow to return to 50% of original value) being directly related to the concentration of peptide applied to the artery (Fig. 2B) . By 3-4 h after endothelin, CBF recovery was evident in an-imals receiving 10-7 and 10-6 M endothelin with flow not significantly different from vehicle controls while flow in animals receiving 10-5 or 10-4 M en dothelin remained significantly reduced.
Neuropathological consequences of endothelin application
All brains from the series were well perfusion fixed with no evidence of intravascular blood or cytological artefacts (e .. g, "dark cells" or "hy dropic cells") (Cammermeyer, 196 1; Brown and Brierly, 1968) . Ischaemic damage as evidenced by the morphological characteristics of early infarction (Brierly and Graham, 1987) was apparent within the MCA territory of rats exposed to endothelin (Fig.  3A) . The areas of ischaemic damage in the ipsilat eral cerebral hemisphere of rats exposed to endo thelin increased progressively with the concentra tion of peptide ( Fig. 4) . These data were used to calculate the total hemispheric volume of ischaemic damage ( Fig. 3B and Table 2 ), which illustrated a correlation between endothelin concentration and the extent of damage. A statistically significant in crease in the volume of ischaemic damage was ap parent at 10-5 and 10-4 M endothelin-l compared to the saline control group (Fig. 3B ).
DISCUSSION
The data presented in this study highlight two important features of endothelin-l -its unique pathological potential as an endogenous peptide and its potential utility as a pharmacological tool capa ble of inducing severe, sustained, but ultimately re versible occlusion of cerebral vessels in vivo.
Pathophysiological significance of endothelin-l
Endothelins are present in neurones, glia, vascu lar smooth muscle, and endothelium (Giaid et aI., 1989; Lee et aI., 1990; MacCumber et aI., 1990; Yoshimoto et aI., 1990; Ehrenreich et aI., 199 1) . However, CNS tissue levels of endothelin-l and en dothelin-3 are extremely low when compared with other centrally occurring peptides (e.g., endothe lin-! concentrations of fmollg compare with pmol/g concentrations for neuropeptide Y). Various stimuli have been shown to induce de novo synthesis and release of endothelin, including hypoxia (Rakugi et aI., 1990) and various factors associated with thrombus formation such as transforming growth factor B, interleukin-l , shear stress, thrombin, and vascular surgery (Kurihara et aI., 1990) . The endo thelium of the cerebral microvasculature has the ca pacity to generate endothelin at least in vitro (Y oshimoto et aI., 1990), and recognition sites for endothelins are present on cerebrovascular smooth muscle (Hoyer et aI., 1989) . Endothelin-l is a potent constrictor of cerebral arteries in vitro (Yanagisawa et aI., 1988; Jansen et aI., 1989; Martin de Aguilera et aI., 1990) and in situ constricts pial vessels and the basilar artery when applied to the adventitial . surface of the vessel (Asano et aI., 1989; Faraci, 1989; . What makes endothelin-l unique among endogenous peptides is not the magnitude of its cerebrovascular effects but rather its extremely prolonged duration. For exam ple, in subarachnoid perivascular microapplication studies in the cat, the time for half maximal resto ration (T'/2) of pial arteriolar calibre after endothe lin-l was between 45 and 60 min ). This compares with TI/2 values, using the same method, of between 1 and 2.5 min for a range of cerebrovascular constrictors, includ ing noradrenaline, neuropeptide Y, barium chlo ride, prostaglandin F2a, and subarachnoid blood (Edvinsson et aI., 1984; McCulloch et aI., 1986a,b) . Systemic administration of endothelin has mini mal effects on CBF or cerebral vessel calibre (Clo zel and Clozel, 1989; Mirna et aI., 1989 ; Kadel et aI., sured by hydrogen clearance in the ipsilateral striatum. Asterisk denotes a significant difference from the saline control (p < 0.05) using statistical analysis described for Fig. 1 . B: T'l, (de fined as the time required for striatal CBF to return to 50% of its original value) following en dothelin-1 (ET-1) or saline appli cation to the exposed middle cerebral artery in the anaesthe tised rat. All data presented as mean ± SO (n = 5-6). 1990) despite occasional claims to the contrary presumably because the blood-brain barrier restricts access of intraluminal polypeptides to the smooth muscle of cerebral re sistance vessels (McCulloch and Edvinsson, 1980; Koseki et aI. , 1989) . Administration of endothelin by routes that cir-cumvent the blood-brain barrier, such as intracis ternal injections (Macrae et aI., 199 1), intrastriatal injections (Fuxe et aI. , 1992) , and onto the adven titial surface of the exposed MCA (Robinson et aI., 1990; present study) , invariably produces marked reductions in CBF that lead to ischaemic damage to cerebral tissue (Fuxe et al. , 1992; present study) death of the animal due to brainstem ischaemia after intracisternal endothelin-l (Macrae et aI. , 199 1). The brain is normally protected from localised va soconstriction of a major cerebral artery by dilata tion of distal vessels to maintain normal levels of perfusion to cerebral tissue (Harper et aI. , 1972) . The evidence from the present studies reveals that the vasoconstriction produced by endothelin over rides such homeostatic mechanisms despite the ves sels constricted by endothelin retaining their ability to respond appropriately to pH and potassium ion concentrates . The present study adds to the growing evidence that exogenous endothelin-l is capable of reducing blood flow to pathologically low levels: a 60% re duction in striatal blood flow has been reported within 20 min of an intrastriatal injection of 0.5 f.Ll of 10 -3 M endothelin-l with evidence of a small stri atal lesion (6 ± 1 mm 3 ) at 3 h (Fuxe et aI. , 1992) . Lower doses of endothelin-l (e. g. , 0. 1 f.LI of 10-5 M) injected into the cortex induced a 40% reduction in cortical flow . In both studies, as in the present study, endothelin-l application induced a prolonged hypoperfusion in the area of application. The critical questions are now to establish the significance of endogenous en dothelins in cerebrovascular pathology. An in creased level of endothelin-l has been reported in canine basilar artery undergoing vasospasm to in tracisternal blood injection (Yamaura et aI. , 1992) and concentrations of endothelin-l and endothelin-3 are elevated in the CSF of patients with subarach noid haemorrhage (Suzuki et aI., 1990; Kraus et aI. , 1991) . However, the concentrations achieved are still below the threshold for vasoconstriction even if one accounts for the increased sensitivity of cere bral vessels after subarachnoid haemorrhage (Ala faci et aI., 1990) . Increased endothelin-like immu noreactivity has been described in response to ex citotoxic injury to the hippocampus (Cintra et aI., 1989) and after permanent MCA occlusion in the rat (Duverger et al. , 1992) . The advent of specific en-dothelin antagonists (Ihara et al., 1992) may facili tate the elucidation of the role played by endoge nous endothelins. In the heart, specific endothelin antibodies, employed as antagonists, have revealed significantly reduced myocardial infarction in a rat model of cardiac ischaemia and reperfusion (Watan abe et ai. 1990 ). Interestingly, cardiac membranes exposed to ischaemia and reperfusion also display an increased density of endothelin binding sites (Lui et aI. , 1990) . In view of the ability of endothelin-l , applied in pmol amounts onto the MCA, to produce sustained reductions in blood flow and ischaemic damage in the territory of the MCA, endothelins will continue to attract considerable cerebrovascu lar interest.
Focal cerebral ischaemia with reperfusion
Permanent occlusion of the MCA by diathermy represents one of the most pertinent and widely used animal models of human cerebral ischaemia. The MCA is reported to be the vessel most com monly affected in stroke syndromes (Mohr et al. , 1986; Karpiak et aI. , 1989) , with the underlying cause most likely to be embolism, which accounts for between 15 and 30% of all cases of stroke. How ever, unlike the animal model in which occlusion of the artery is permanent, persistence of embolic oc clusion is the exception rather than the rule in hu man MCA occlusion, where some degree of spon taneous reperfusion occurs in the majority of pa tients (Olsen and Lassen, 1984; Mohr et aI., 1986; Yamaguchi et aI. , 1987) . Early reperfusion through an occluded artery is known to be beneficial to final outcome while delayed or late reperfusion is poten tially deleterious (Watson, 1989) . One explanation for this phenomenon is that in addition to the pri mary excitotoxic damage instigated during the isch aemic phase, secondary reperfusion injury may arise (e. g. , with increased free radical and ei cosanoid production, oedema formation, and possi ble vessel injury and haemorrhagic transformation), which can exacerbate the damage. Whether late reperfusion per se can cause the death of viable and hence potentially salvageable tissue remains a mat ter for debate and highlights the need for carefully designed studies to provide conclusive evidence.
Since reperfusion injury cannot be studied in per manent occlusion models, various attempts have been made to develop reperfusion models of focal ischaemia using microclips, ligatures, intraluminal occlusion with filaments, etc. (Tamura et aI., 1980; Nagasawa and Kogure, 1989; Selman et aI., 199 1) . Unfortunately, manipulation of the M CA during vessel occlusion has the attendant risk of causing secondary pathological events related to uncon trolled damage to the endothelium or smooth mus cle. Reliable recirculation is known to be hampered by direct mechanical damage to the vessel wall with consequent variability in the distribution of CBF and infarction (e.g., Tamura et aI., 1980) .
In this study, we have developed a new model of focal cerebral ischaemia that incorporates an initial profound oligaemia and a secondary phase of reper fusion in the territory of the MCA. Ischaemia is induced by application of the vasoconstrictor pep tide endothelin-l directly onto the exposed MCA in the anaesthetised rat. The results presented demon strate the severity and duration of the effects of endothelin-l on the cerebral vasculature (Fig. 2) . The effects of the higher concentrations of endothe lin were sufficiently severe and prolonged to main tain flow below the threshold for ischaemic damage (Symon et aI., 1977; Jones et aI., 198 1; Tamura et aI., 1981 b) . Clear neuropathological evidence of tis sue damage was evident 4 h after endothelin appli cation ( Figs. 3 and 4) with the extent of damage related to the concentration of endothelin applied. At 10-4 M endothelin, the total volume of isch aemic damage was broadly similar to values re ported for permanent MCA occlusion (Park et aI., 1988) . The fact that the magnitude and duration of the oligaemia were dose related allows some degree of external control over the extent of insult pro duced. In addition, the efficacy of this model in inducing extensive tissue damage supports the hy pothesis that the extent of tissue damage or oedema formation is exacerbated where ischaemia is incom plete (a very low level of flow being maintained throughout) or followed by reperfusion (Gamache, 1987; Koizumi et aI., 1989) .
As with all models of reversible cerebral isch aemia, variability is greater than in permanent oc clusion models because of additional variables in troduced during the reperfusion phase. Stringent monitoring of blood pressure, anaesthetic status, blood gases, plasma glucose, and temperature limits variability to within acceptable limits. However, J Cereb Blood Flow Metab, Vol. 13, No.2, 1993 larger group sizes will be inevitable in the evalua tion of anti-ischaemic drugs. Power analysis (see the Materials and Methods section) has been em ployed to estimate group sizes necessary to avoid a type 2 error for a preselected difference in infarct volume between control and drug-treated groups. For the endothelin (10-5 M) model, a group size of 17 is predicted for a 50% reduction in infarct volume to be consistently recorded as statistically signifi cant at the 5% level. This compares with group sizes of 12 (Gotoh et aI., 1986) and 8 (Park et aI., 1988) necessary to fulfill the same conditions in per manent MCA occlusion models (using Sprague Dawley rats, a 4-h time point, and quantitative his topathology). With regard to drug studies, caution should also be exercised in using the endothelin reperfusion model to assess the efficacy of calcium channel blockers since dihydropyridines have been shown to attenuate (but not abolish) endothelin induced contractions in vitro (Jansen et aI. , 1989; Martin de Aguilera et aI., 1990) .
In conclusion, in this study, the unique ability of endothelin-l to induce sustained cerebrovascular constriction has been harnessed to develop and characterise a new model of reversible focal cere bral ischaemia consistent with the development of tissue infarction. This model will hopefully promote future research on both ischaemic and reperfusion injury within the CNS and stimulate further interest in the putative role for endothelin per se as a medi ator of cerebral ischaemic damage.
